THC vs CBD

THC is intoxicating, while CBD is not. Both can have side effects.[17] Compare their medical uses, addiction concerns, drug-test risks, and legal status, with practical steps for getting answers and support.

Jessica Miller is the Content Manager of Addiction HelpWritten by
Kent S. Hoffman, D.O. is a founder of Addiction HelpMedically reviewed by Kent S. Hoffman, D.O.
Last updated

Battling addiction & ready for help?

Find Treatment Now

What Is the Main Difference Between THC and CBD?

THC produces the cannabis high. CBD does not. Both come from the cannabis plant, but they affect the body differently. That distinction matters when you are comparing medical uses, side effects, addiction concerns, or the possibility of a positive drug test.[17]

Understanding the difference also means separating the compound from the product. A prescription cannabinoid medicine, a cannabis edible, and an oil labeled CBD are not interchangeable. Their ingredients, doses, and evidence can differ substantially.[12][17]

Fast Facts About THC vs CBD
  • THC is intoxicating, while CBD is not. CBD can still reduce alertness and cause other side effects.[17]
  • Prescription CBD has several approved seizure indications. Epidiolex treats seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients age 1 and older.[12]
  • THC-containing cannabis can lead to addiction and withdrawal. Difficulty cutting back, cravings, and continued use despite problems are reasons to seek support.[16][17]
  • A CBD product can contain THC. Inaccurate labeling can create unexpected effects and drug-test concerns.[13][17]
  • CBD can interact with medicines. A pharmacist or prescriber can review the product, intended dose, and your medication list for specific interaction risks.[6]

THC Is the Intoxicating Cannabinoid

THC, short for tetrahydrocannabinol, is the main compound responsible for the cannabis high. It can change perception, thinking, memory, and body movement. Some people feel happier or relaxed, while others experience anxiety, panic, or paranoia, especially with larger amounts or high-THC products.[2][17]

THC also has medical uses in specific prescription medicines. Being intoxicating does not rule out a therapeutic benefit, but it does make the dose, formulation, and effects on daily functioning important.[14][17]

CBD Is Non-Intoxicating, Not Free of Side Effects

CBD, or cannabidiol, does not produce a THC-like high. Non-intoxicating does not mean it cannot affect alertness or health. CBD can cause drowsiness, gastrointestinal symptoms, and medication interactions, and it has been associated with liver injury.[17]

That distinction helps explain why a CBD product may make someone sleepy without making them high. It also means that a product marketed for calm or wellness still deserves the same attention to ingredients and interactions as other biologically active products.[6][17]

THC vs CBD: effects, medical uses, safety concerns, drug testing, and U.S. legal considerations
Feature THC CBD
Produces a high Yes. THC is the main intoxicating compound in cannabis.[2][17] No THC-like high, although alertness can decrease.[17]
Receptor activity Partially activates cannabinoid CB1 and CB2 receptors.[2] Interacts with cannabinoid signaling differently and does not activate these receptors in the same way as THC.[2]
Established medical uses Prescription dronabinol treats chemotherapy-related nausea and vomiting and appetite or weight-loss problems associated with HIV/AIDS.[14] Purified prescription CBD treats seizures associated with three specified conditions in patients age 1 and older.[12]
Main safety concerns Impaired thinking and movement, anxiety or paranoia, and the potential for cannabis use disorder and withdrawal.[16][17] Reduced alertness, gastrointestinal symptoms, medication interactions, and possible liver injury.[6][17]
Drug-test concerns Cannabis urine tests commonly look for a THC breakdown product.[5] Pure CBD did not produce a confirmed positive under federal workplace thresholds in a small acute-dose study. THC-containing CBD products can produce positive results.[5]
U.S. legal status Product-specific. An April 2026 rule covers specified medical marijuana products, not all THC products.[15] Hemp-related status does not make a product FDA-approved or lawful as a dietary supplement or food sold in interstate commerce with added CBD.[12]

THC and CBD Legal Status Depends on the Product and Date

An April 28, 2026 federal rule places FDA-approved marijuana-containing drug products and marijuana covered by state medical marijuana licenses in Schedule III, with federal registration and other requirements. It does not move all THC products into Schedule III or legalize nonmedical marijuana.[15]

The rule also notes a hemp-definition change scheduled for November 12, 2026. Check the official federal rule and current state requirements rather than assuming that a particular THC percentage guarantees legality.[15]

Controlled-substance scheduling is separate from FDA approval and food rules. FDA states that THC and CBD cannot be marketed as dietary supplements and that foods with added THC or CBD cannot be sold in interstate commerce.[12]

How THC and CBD Affect the Endocannabinoid System

THC and CBD interact differently with the body’s cannabinoid signaling system. THC activates cannabinoid receptors, while CBD does not activate them in the same way. Their effects are not simply opposites, and adding CBD does not reliably cancel THC’s effects.[2][8]

Both compounds are cannabinoids. The endocannabinoid system includes receptors and signaling chemicals the body makes itself. Plant cannabinoids can interact with that system, but their molecular differences change how they act.[2]

THC Activates Cannabinoid Receptors

THC is a partial agonist at CB1 and CB2 receptors, meaning it activates them without producing the maximum activation possible. Its action at the brain’s CB1 receptors helps explain the high.[2]

This receptor activity helps explain why THC can change several experiences at once, including perception, memory, and movement. The effect is not always relaxation. Anxiety, distrust, or panic can also occur, particularly with larger amounts or high-THC products.[2][17]

CBD Does Not Act Like THC at These Receptors

CBD has different receptor pharmacology from THC. Laboratory research describes ways it can oppose some cannabinoid-receptor activation, rather than acting as THC does. That does not establish that CBD always calms people or explain its seizure benefits through one simple mechanism.[2]

Different Effects, Not an On-Off Switch

THC and CBD are not two settings on the same switch. Their receptor activity differs, and a laboratory finding about that activity does not by itself prove a treatment benefit or show that CBD makes THC safe.[2][8]

Can CBD Counteract a THC High?

CBD is not a reliable antidote to a THC high. One controlled study found specific benefits when CBD was given before THC, but it did not test whether a retail CBD product could reverse an existing high.[8]

In that study, 48 healthy participants received 600 mg of oral CBD or placebo 210 minutes before 1.5 mg of intravenous THC.[8] The CBD group experienced less paranoia and less impairment on a memory test.[8]

The difference in overall positive psychotic-symptom scores was not statistically significant. These results do not establish that CBD prevents psychotic disorders or that a particular dispensary THC-to-CBD ratio is protective. The study’s doses and timing describe an experiment, not a recommended way to combine the compounds.[8]

THC vs CBD Medical Uses and Evidence

Both THC-related medicines and purified prescription CBD have established medical uses, but they treat different conditions. Evidence for a specific medicine and diagnosis does not establish that a retail gummy, oil, or cannabis product will provide the same benefit.[12][14]

Prescription CBD Treats Seizures Associated With Specific Conditions

Epidiolex contains purified CBD. FDA has approved it for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients age 1 and older. It is one approved CBD product with several indications, not a general wellness treatment.[12]

A 2017 trial illustrates the benefit measured in Dravet syndrome. Researchers assigned 120 children and young adults with drug-resistant seizures to CBD oral solution at 20 mg per kilogram of body weight per day or placebo, alongside their usual antiseizure treatment, for 14 weeks.[4]

Median monthly convulsive seizures decreased from 12.4 to 5.9 with CBD, compared with 14.9 to 14.1 with placebo.[4] That was a meaningful reduction in convulsive seizures, not a cure. Side effects, including diarrhea, fatigue, sleepiness, and abnormal liver-function tests, were more frequent with CBD.[4]

Prescription CBD and Retail CBD Are Not Interchangeable

Epidiolex has been evaluated as a specific drug product for specified uses. Other CBD products have not received that approval, and FDA has not established their effectiveness, proper dosage, or safety through the drug-approval process.[12]

Prescription THC Has Uses for Chemotherapy Symptoms and HIV/AIDS

Dronabinol, a synthetic form of THC, is used for nausea and vomiting caused by cancer chemotherapy and for loss of appetite and weight loss in people with HIV/AIDS. It is not a general-purpose appetite medicine.[14]

FDA-approved products containing dronabinol include Marinol and Syndros. Nabilone, sold as Cesamet, is a related synthetic compound used for chemotherapy-related nausea and vomiting. These are prescription treatments, not evidence that every THC-containing product has the same medical effects.[12][14]

Cannabinoids May Help Chronic Pain and Spasticity

A 2015 systematic review found moderate-quality evidence supporting cannabinoids for chronic pain and spasticity. Evidence for chemotherapy-related nausea and vomiting was rated low quality, not equally strong. The review covered different cannabinoid preparations and also found an increased risk of short-term side effects.[1]

The size of a benefit matters. NCCIH describes a 2018 review in which 29% of people taking cannabis or cannabinoids had at least a 30% reduction in chronic noncancer pain, compared with 26% taking placebo.[14]

NCCIH notes that this difference may be too small to be meaningful to patients, and side effects were more common with cannabis or cannabinoids than with placebo. It is also not evidence specifically for retail CBD alone.[14]

CBD Evidence for Anxiety Is Preliminary

CBD reduced anxiety during a public-speaking task in a small trial, but that does not establish it as an everyday anxiety treatment. The study included 24 people with untreated social anxiety disorder who received a single 600 mg dose of CBD or placebo before simulated public speaking.[9]

That result is encouraging for further research. It does not establish long-term benefit, treatment of other anxiety disorders, or an effective dose for retail gummies and oils. FDA has not approved a CBD drug for anxiety, sleep, or general wellness.[9][12]

THC and CBD Side Effects and Addiction Risks

THC’s important risks include intoxication and cannabis use disorder. CBD has a different set of documented concerns, including reduced alertness, medication interactions, and liver injury. Cannabis products can also have inaccurate labels or contaminants, so not every product-related harm can be attributed to THC alone.[16][17]

For a broader look at physical and mental effects, see marijuana’s effects. The comparison below focuses on what matters when distinguishing THC from CBD.

THC Addiction and Physical Dependence Are Related but Different

THC-containing cannabis can become difficult to control. CDC identifies warning signs such as using more than intended, unsuccessful attempts to quit, cravings, and continued use despite problems at home, school, or work. Risk is greater for people who use cannabis daily or nearly daily and who began using it before age 18.[16]

A frequently cited U.S. survey found that 30.6% of adult past-year cannabis users met DSM-IV criteria for marijuana abuse or dependence in 2012–2013.[7] That is a dated estimate using that study’s diagnostic criteria, not a current rate for everyone who uses cannabis or a measure of CBD addiction.[7]

Dependence Is Not the Same as Addiction

Physical dependence means withdrawal may occur when use stops or decreases. Addiction involves difficulty controlling use despite harm. NIH notes that withdrawal can occur after heavy or long-term cannabis use even without cannabis use disorder. Needing help with either is not a personal failure.[16][17]

Withdrawal can include irritability, trouble sleeping, decreased appetite, and low mood. Recognizing those symptoms can help explain why cutting back feels harder than expected.[17] Learn more about marijuana withdrawal symptoms and whether marijuana is addictive.

THC Can Impair Thinking and Is Linked to Psychosis Risk

THC-containing cannabis can interfere with thinking, memory, and body movement. Anxiety, panic, and hallucinations are more common with large amounts or high-THC products, particularly in people with little cannabis experience. Impairment also makes activities such as driving unsafe.[16][17]

A study using 2010–2015 data from 11 sites in Europe and Brazil compared 901 people with first-episode psychosis with 1,237 controls.[3] Daily use of high-potency cannabis, categorized by the expected THC concentration of the cannabis type (at least 10%), was associated with 4.8 times the adjusted odds of psychotic disorder compared with never using cannabis.[3]

That finding is an association, not proof that cannabis caused each person’s illness or a prediction of anyone’s absolute risk. It identifies daily high-potency use as an important pattern to consider when discussing cannabis and mental health.[3]

How a product is taken matters, too. CDC notes that cannabis edibles and beverages can take up to two hours to produce noticeable effects, which can contribute to taking too much.[16] Our guide to marijuana edibles explains those product-specific concerns.

Historical Potency Data Show Why THC Strength Matters

In an analysis of 38,681 cannabis preparations seized by the DEA between 1995 and 2014, average THC potency in plant material rose from about 4% to about 12%.[11] Average CBD content fell from about 0.28% in 2001 to below 0.15% in 2014.[11] These are historical seizure data, not measurements of every product sold today.[11]

The study documents a shift in the tested material. It does not establish that declining CBD caused greater harm or that CBD in a product reliably protects against THC’s effects.[11][8]

CBD Can Cause Side Effects and Medication Interactions

CBD can cause sleepiness and gastrointestinal symptoms, and prescription-dose research has found abnormal liver-function tests. These effects deserve attention even when a person never feels high.[4][17]

CBD can affect pathways involved in processing other medicines, potentially changing drug levels or effects. Other medicines can also affect CBD. A medication review therefore needs to consider both directions of an interaction, rather than treating CBD as an inactive supplement.[6]

Bring a pharmacist or prescriber the product name, labeled CBD and THC amounts, intended dose, and a list of medicines and supplements. Ask: “Could this change my medicine levels, increase sedation, or require liver monitoring?” That review can identify specific interactions and whether monitoring or an alternative is appropriate.[6][17]

Why CBD Products Can Lead to a Positive Drug Test

A CBD product can lead to a positive cannabis test if it contains THC. The CBD label does not guarantee what is inside, and testing method and timing matter as well as the product’s contents.[5][13][17]

CBD Labels Do Not Guarantee That THC Is Absent

NIH reports that some CBD products contain different amounts of CBD than their labels show and that some products marketed as CBD contain THC. That makes the actual contents more important than the product’s name or wellness claims.[17]

Check Both CBD and THC Information

Look for the labeled amounts of both compounds, but do not treat “THC-free” as a promise that you will pass a test. DOT warns that CBD products may contain more THC than their labels state and that FDA does not certify those THC levels.[13]

What the CBD Urine-Test Study Found

A controlled study in six healthy adults tested single doses of 100 mg of pure CBD taken orally or by vaporization.[5] It also tested vaporized CBD-dominant cannabis containing 100 mg of CBD and 3.7 mg of THC.[5]

Pure CBD did not produce a positive result under federal workplace testing thresholds of 50 ng/mL for screening and 15 ng/mL for confirmation.[5] One specimen screened positive at a lower 20 ng/mL threshold, but no pure-CBD specimen exceeded the confirmatory cutoff.[5] Some specimens after the THC-containing cannabis did produce confirmed positives.[5]

These tests measured a THC metabolite, or breakdown product, rather than CBD itself. The small, acute-dose study does not guarantee a negative result with every CBD product or testing method.[5] For detection timing, see how long weed stays in your system.

CBD Use Does Not Override a Workplace Testing Policy

For DOT-regulated safety-sensitive employees, CBD use is not accepted as a medical explanation for a laboratory-confirmed marijuana-positive result. That notice applies to DOT testing, not automatically to every employer.[13]

If testing could affect your job, review the applicable policy and ask the testing program or medical review officer how results are handled. A seller’s assurance about a CBD product is not a substitute for understanding that policy.

Getting Help for THC Addiction or Dependence

Help for THC addiction focuses on changing the patterns that keep cannabis use going. Cognitive behavioral therapy, motivational enhancement therapy, and contingency management can reduce cannabis use and related problems.[10][17] You can seek support before those problems become a crisis.

If you keep using more than intended, cannot cut back, or find cannabis crowding out important activities, those are useful things to discuss with a clinician or counselor.[16] Our guide to marijuana addiction explains how to recognize the problem and begin looking for help.

Counseling Builds Skills for Cravings, Triggers, and Change

Cognitive behavioral therapy helps identify the thoughts, routines, and outside triggers connected with cannabis use. It teaches coping and problem-solving skills, with practice between sessions so those skills can be used in everyday situations.[18]

Motivational enhancement therapy helps people work through mixed feelings about changing their cannabis use. Personalized feedback and education help connect a person’s use patterns with their own reasons for change, rather than requiring them to arrive already certain about every next step.[18]

These approaches can substantially reduce cannabis use and related problems, although lasting abstinence was not a common outcome in a 2021 review. Treatment offers useful tools, not a guaranteed or overnight result.[10]

NIH reports that there are no FDA-approved medicines for cannabis use disorder or medically assisted cannabis withdrawal.[17] A practical first step is to tell a clinician what you use, how often, what happens when you stop, and what you want to change. That gives the conversation a clear starting point.

More on marijuana:

You do not have to wait for a crisis to ask for help.

Explore online therapy options →

Frequently asked questions

How Are THC and CBD Different?

THC produces the cannabis high, while CBD does not. THC can alter perception, thinking, memory, and movement. CBD is non-intoxicating, but it can still reduce alertness, cause gastrointestinal symptoms, interact with medicines, and affect the liver.[17]

Both have medical applications in specific prescription products. Those approvals do not make retail cannabis or CBD products interchangeable with the approved medicines.[12][14]

Does CBD Get You High?

No. CBD itself does not produce a THC-like high, although it can make someone less alert or sleepy.[17] Feeling high after taking a product labeled CBD is a reason to question its contents, not proof that CBD causes intoxication. Some products marketed as CBD contain THC, and labels can be inaccurate.[17]

Is CBD Actually Proven to Work for Anything?

Yes. Epidiolex, a purified prescription CBD medicine, is FDA-approved for seizures associated with Lennox-Gastaut syndrome, Dravet syndrome, and tuberous sclerosis complex in patients age 1 and older.[12] A controlled Dravet syndrome trial found a greater reduction in convulsive seizures with CBD than placebo, alongside more side effects.[4]

Anxiety findings are preliminary. A trial in 24 people with untreated social anxiety disorder found that a single 600 mg dose reduced anxiety during simulated public speaking.[9] It did not establish long-term benefit or a recommended dose for retail CBD products.[9]

Will CBD Make You Fail a Drug Test?

A CBD product can lead to a positive cannabis test if it contains THC. In a six-person acute-dose study, pure CBD did not produce a confirmed positive under federal workplace thresholds, while CBD-dominant cannabis containing THC produced some confirmed positives. That finding does not guarantee results for every product or test.[5]

Labels may not accurately report THC content. For DOT-regulated safety-sensitive employees, CBD use is not accepted as a medical explanation for a confirmed marijuana-positive result. Other workers should check their own testing policy.[13]

Which One Is Responsible for Marijuana's Risks?

THC is responsible for cannabis intoxication, and THC-containing cannabis can lead to impaired functioning, cannabis use disorder, and withdrawal.[16][17] Daily high-potency cannabis use has also been associated with higher odds of psychotic disorder, although that association does not predict an individual’s outcome.[3]

Not every cannabis-product risk comes from THC. CBD can cause side effects and medication interactions, and cannabis or cannabinoid products may have inaccurate labels or contaminants.[17]

Is CBD Completely Safe?

No. CBD can reduce alertness, cause gastrointestinal symptoms, interact with medicines, and affect the liver.[17] The amount taken and other medications matter when assessing those risks.[6]

Bring a pharmacist or prescriber the product name, labeled CBD and THC amounts, intended dose, and your medication list. Ask whether CBD could change medicine levels, increase sedation, or require monitoring. That provides a more useful safety review than relying on a “natural” or wellness label.[6]

Get Treatment Help

If you or someone you love is struggling with addiction, getting help is just a phone call away, or consider trying therapy online with BetterHelp.

Exclusive offer: 20% Off BetterHelp*

Following links to the BetterHelp website may earn us a commission that helps us manage and maintain AddictionHelp.com. *Get 20% off your first month of BetterHelp. Offer valid for new BetterHelp users only. Offer cannot be combined with insurance.

18 Sources
  1. Whiting PF, Wolff RF, Deshpande S, Di Nisio M, Duffy S, Hernandez AV, Keurentjes JC, Lang S, Misso K, Ryder S, Schmidlkofer S, Westwood M, Kleijnen J. (2015). Cannabinoids for Medical Use: A Systematic Review and Meta-analysis. Read source
  2. Pertwee RG. (2008). The diverse CB1 and CB2 receptor pharmacology of three plant cannabinoids: delta9-tetrahydrocannabinol, cannabidiol and delta9-tetrahydrocannabivarin. Read source
  3. Di Forti M, Quattrone D, Freeman TP, Tripoli G, Gayer-Anderson C, Quigley H, Rodriguez V, Jongsma HE, Ferraro L, La Cascia C, La Barbera D, Tarricone I, Berardi D, Szöke A, Arango C, Tortelli A, Velthorst E, Bernardo M, Del-Ben CM, Menezes PR, Selten JP, Jones PB, Kirkbride JB, Rutten BP, de Haan L, Sham PC, van Os J, Lewis CM, Lynskey M, Morgan C, Murray RM, EU-GEI WP2 Group. (2019). The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study. Read source
  4. Devinsky O, Cross JH, Laux L, Marsh E, Miller I, Nabbout R, Scheffer IE, Thiele EA, Wright S, Cannabidiol in Dravet Syndrome Study Group. (2017). Trial of Cannabidiol for Drug-Resistant Seizures in the Dravet Syndrome. Read source
  5. Spindle TR, Cone EJ, Kuntz D, Mitchell JM, Bigelow GE, Flegel R, Vandrey R. (2020). Urinary Pharmacokinetic Profile of Cannabinoids Following Administration of Vaporized and Oral Cannabidiol and Vaporized CBD-Dominant Cannabis. Read source
  6. Brown JD, Winterstein AG. (2019). Potential Adverse Drug Events and Drug-Drug Interactions with Medical and Consumer Cannabidiol (CBD) Use. Read source
  7. Hasin DS, Saha TD, Kerridge BT, Goldstein RB, Chou SP, Zhang H, Jung J, Pickering RP, Ruan WJ, Smith SM, Huang B, Grant BF. (2015). Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013. Read source
  8. Englund A, Morrison PD, Nottage J, Hague D, Kane F, Bonaccorso S, Stone JM, Reichenberg A, Brenneisen R, Holt D, Feilding A, Walker L, Murray RM, Kapur S. (2013). Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment. Read source
  9. Bergamaschi MM, Queiroz RH, Chagas MH, de Oliveira DC, De Martinis BS, Kapczinski F, Quevedo J, Roesler R, Schröder N, Nardi AE, Martín-Santos R, Hallak JE, Zuardi AW, Crippa JA. (2011). Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients. Read source
  10. Connor JP, Stjepanović D, Le Foll B, Hoch E, Budney AJ, Hall WD. (2021). Cannabis use and cannabis use disorder. Read source
  11. ElSohly MA, Mehmedic Z, Foster S, Gon C, Chandra S, Church JC. (2016). Changes in Cannabis Potency Over the Last 2 Decades (1995-2014): Analysis of Current Data in the United States. Read source
  12. U.S. Food and Drug Administration. (n.d.). FDA regulation of cannabis and cannabis-derived products, including cannabidiol (CBD). Read source
  13. U.S. Department of Transportation. (2020, February 18). DOT CBD notice. Read source
  14. National Center for Complementary and Integrative Health. (n.d.). Cannabis (marijuana) and cannabinoids: What you need to know. Read source
  15. Drug Enforcement Administration. (2026, April 28). Schedules of controlled substances: Rescheduling of Food and Drug Administration approved products containing marijuana from Schedule I to Schedule III. Federal Register, 91, 22714. Read source
  16. Centers for Disease Control and Prevention (2025). Cannabis frequently asked questions. Read source
  17. National Institutes of Health (n.d.). Cannabis. Read source
  18. National Institute of Justice. (2020, October 19). Practice profile: Psychosocial interventions for cannabis use disorder. Read source
Written by
Jessica Miller is the Content Manager of Addiction Help

Editorial Director

Jessica Miller is the Editorial Director of Addiction Help. Jessica graduated from the University of South Florida (USF) with an English degree and combines her writing expertise and passion for helping others to deliver reliable information to those impacted by addiction. Informed by her personal journey to recovery and support of loved ones in sobriety, Jessica's empathetic and authentic approach resonates deeply with the Addiction Help community.

Reviewed by
  • Fact-Checked
  • Editor
Kent S. Hoffman, D.O. is a founder of Addiction Help

Co-Founder & Chief Medical Officer

Kent S. Hoffman, D.O. has been an expert in addiction medicine for more than 15 years. In addition to managing a successful family medical practice, Dr. Hoffman is board certified in addiction medicine by the American Osteopathic Academy of Addiction Medicine (AOAAM). Dr. Hoffman has successfully treated hundreds of patients battling addiction. Dr. Hoffman is the Co-Founder and Chief Medical Officer of AddictionHelp.com and ensures the website’s medical content and messaging quality.

Real Help. Real Recovery.

Compare centers, explore options and start your path to recovery today.

Find Treatment Now

"AddictionHelp.com is helping to make recovery available to EVERYONE!"

- Angela N.